Immunogenicity postvaccination (RSVpreF-elicited immune responses) was evaluated as antibody neutralization ... a single dose of the bivalent RSVpreF vaccine administered to ≥ 60-year-olds ...

For patients with hybrid immunity from prior infection, the adjusted VE of the bivalent vaccine was 62.2% (95% CI ... and the possibility of undetected infections due to antibody waning.

The Moderna laboratories Tuesday reported that their two bivalent Omicron-targeting new messenger RNA (mRNA) technology booster vaccines (mRNA-1273.214 and mRNA-1273.222) have a superior antibody ...

Taichengsi (Shanghai) Biomedical Co. Ltd. has described antibody-drug conjugates comprising an antibody covalently bound to a cytotoxic drug through a bivalent olefin linker optionally consisting of ...

The new version – dubbed Spikevax Bivalent Original/Omicron – has ... which showed it was better at stimulating neutralising antibodies against BA.1 than the original Spikevax.

The “bivalent vaccine” will be made available ... is more effective than existing vaccines in producing neutralizing antibodies that can defend against an array of Omicron variants.